56 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
of delaying, deferring or discouraging another party from acquiring control of our company by means of a tender offer, a proxy contest or otherwise
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
of a tender offer, a proxy contest or otherwise, or may affect the price an acquiring party would be willing to offer in such an instance. The material
424B5
qp8wds 9oq1txjlbr
23 Jun 22
Prospectus supplement for primary offering
4:09pm
424B5
xzm5tylo9tat8112x7t
22 Jun 22
Prospectus supplement for primary offering
4:05pm
424B5
6ze55kj91qumm
1 Mar 22
Prospectus supplement for primary offering
5:12pm
424B5
1iedo8l6b9qi6
6 Oct 21
Prospectus supplement for primary offering
5:05pm
424B5
pebfhtu5tvh8j gpp9k
4 Oct 21
Prospectus supplement for primary offering
5:27pm
424B5
3qqewgj jtib0klj
9 Mar 21
Prospectus supplement for primary offering
5:26pm